Document is current
Any future updates will be listed below
-
Authors
Zhu, Dantong
Wu, Judy Z.
Griffin, Patrick T.
Samuelson, Brady A.
Sinclair, David A.
Kane, Alice E.
-
Funding
Funding for this research was provided by:
National Institute on Aging (R00AG070102, R01AG019719)
- License Information
-
More Information
Article History
Received: 21 January 2025
Accepted: 12 May 2025
First Online: 23 May 2025
Competing interests
: D.A.S. is a founder, equity owner, advisor to, director of, board member of, consultant to, investor in and/or inventor on patents licensed to Revere Biosensors, UpRNA, GlaxoSmithKline, Wellomics, DaVinci Logic, InsideTracker (Segterra), Caudalie, Animal Biosciences, Longwood Fund, Catalio Capital Management, Frontier Acquisition Corporation, AFAR (American Federation for Aging Research), Life Extension Advocacy Foundation (LEAF), Cohbar, Galilei, EMD Millipore, Zymo Research, Immetas, Bayer Crop Science, EdenRoc Sciences (and affiliates Arc-Bio, Dovetail Genomics, Claret Bioscience, MetroBiotech, Astrea, Liberty Biosecurity and Delavie), Life Biosciences, Alterity, ATAI Life Sciences, Levels Health, Tally (aka Longevity Sciences) and Bold Capital. D.A.S. is an inventor on a patent application filed by Mayo Clinic and Harvard Medical School that has been licensed to Elysium Health. Additional info on D.A.S. affiliations can be found at . The other authors declare no competing interests.
